Kaposi sarcoma–associated herpesvirus (KSHV), also known as human herpesvirus 8, is
the etiologic agent underlying Kaposi sarcoma, primary effusion lymphoma, and multicentric …

Viruses successfully infect host cells by initially binding to the surfaces of the cells, followed
by an intricate entry process. As multifunctional heterodimeric cell-surface receptor …

Arbidol (ARB) is a synthetic antiviral originally developed to combat influenza viruses. ARB
is currently used clinically in several countries but not in North America. We have previously …

It is becoming increasingly clear that herpesviruses can exploit the endocytic pathway to
infect cells, yet several important features of this process remain poorly defined. Using …

The proteins that compose a herpesvirus virion are thought to contain the functional
information required for de novo infection, as well as virion assembly and egress. To …

Epstein–Barr virus (EBV; human herpesvirus 4; HHV‐4) and Kaposi sarcoma‐associated
herpesvirus (KSHV; human herpesvirus 8; HHV‐8) are human gammaherpesviruses that …

Kaposi's sarcoma–associated herpesvirus (KSHV) has been implicated in the pathogenesis
of Kaposi's sarcoma (KS) and other malignancies. The cellular origin of KS has been …

Kaposi's sarcoma-associated herpesvirus (KSHV) infection of in vitro target cells is
characterized by the expression of the latency-associated open reading frame (ORF) 73 …

Kaposi's sarcoma–associated herpesvirus (KSHV) is the causative agent of Kaposi's
sarcoma, a highly vascularized tumor originating from lymphatic endothelial cells, and of at …

When searching for their favorite host tissues, animal viruses frequently attach to cell-surface
receptors that have key roles in normal cell physiology. Integrins are prime examples of …